Skip to main content
. 2012 Oct 17;7(10):e47106. doi: 10.1371/journal.pone.0047106

Table 1. A list of patients included in GnRH agonist and GnRH antagonist group with a number CC samples regarding to oocyte stage.

Patient Therapy group CC MI CC MII-NF CC MI-BL
1 GnRH agonist 1 1
2 GnRH agonist 1 1 1
3 GnRH agonist 1 1
4 GnRH agonist 1 1
5 GnRH agonist 1 1 1
6 GnRH agonist 1 1 1
7 GnRH agonist 1 1
8 GnRH agonist 1 1
9 GnRH agonist 1 1
10 GnRH agonist 2 1
11 GnRH agonist 1 1
12 GnRH antagonist 1 1
13 GnRH antagonist 1 1
14 GnRH antagonist 1 1
15 GnRH antagonist 1 1
16 GnRH antagonist 1 1
17 GnRH antagonist 1 1
18 GnRH antagonist 1 1
19 GnRH antagonist 1 1
20 GnRH antagonist 1 1
21 GnRH antagonist 1 1

CC MI: cumulus cells of metaphase I oocytes; CC MII-NF: cumulus cells of unfertilized metaphase II oocytes; CC MII-BL: cumulus cells of metaphase II oocytes developed to blastocyst stage embryo.